In other countries
The same active substances on other registers, the same brand first.
- SPITOMIN 10 mgRomania · 10mg · compr. · Egis Pharmaceuticals PLCSame form
- SPITOMIN 5 mgRomania · 5mg · compr. · Egis Pharmaceuticals PLCSame form
- Amb-BuspironeCanada · 10 MG · Tablet · Ambicare Pharmaceuticals INC.Same substance
- Auro-BuspironeCanada · 10 MG · Tablet · Auro Pharma INCSame substance
- Buspirone TabletsCanada · 10 MG · Tablet · Sanis Health INCSame substance
- Buspiron HCl CF 10 mg, tablettenNetherlands · Tablet · Centrafarm B.V.Same substance
- Buspiron HCl Mylan 10 mg, tablettenNetherlands · Tablet · Mylan Pharmaceuticals LimitedSame substance
- Buspiron HCl Sandoz 10 mg, tablettenNetherlands · Tablet · Sandoz B.V.Same substance
- Buspirone ViatrisNew Zealand · Tab 5 mgSame substance
- Buspirone ViatrisNew Zealand · Tab 10 mgSame substance
- Buspar 10MG TabSaudi Arabia · SpimacoSame substance
- Buspar 5MG TabSaudi Arabia · SpimacoSame substance
- BucapsolUnited States · 10MG, 15MG, 5MG … · capsule · Epic Pharma LLCSame substance
- Buspirone HydrochlorideUnited States · 10MG, 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 12.5MG … · tablet · Aurobindo Pharma LTDSame substance
- BusparUnited States · 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · tablet · Bristol Myers SquibbSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Buspirone
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 24 Oct 2025
- Registration
- 103720322
- Marketing authorisation holder
- Supera Farma Laboratórios S.A
- Procedure
- Registered